Novartis gets FDA approval for chronic idiopathic urticaria drug

Singapore: US Food and Drug Administration (FDA) has approved Novartis' Xolair (omalizumab) for the treatment of chronic...

March 25, 2014 | Tuesday | News
Drug developed in New Zealand gets go ahead for trial

Singapore: The US Food and Drug Administration (FDA) has granted approval for PR610, an anticancer "stealth" drug invent...

August 30, 2012 | Thursday | Regulatory
FDA approves Merck's Keytruda for advanced lung cancer

Merck announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA (pembrolizumab)monotherapy, the c...

October 7, 2015 | Wednesday | News
AstraZeneca, KHIDI setup cancer research program

Singapore: AstraZeneca signed a memorandum of understanding (MoU) with the Korea Health Industry Development Institute (...

March 11, 2014 | Tuesday | News
FDA approves SNDA for BMS-Pfizer DVT prevention drug

Singapore: U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application (sNDA), co-developed...

March 19, 2014 | Wednesday | News
BioPharma Asia: Bionomics wins Innovative Asian Biotech of the Year Award

Singapore: Australia based Bionomics is recognized as the Innovative Asian Biotech of the Year at BioPharma Asia Industr...

March 17, 2014 | Monday | News
Australia approves drug for cystic fibrosis

Singapore: US-based Vertex Pharmaceuticals has received Therapeutic Goods Administration (TGA) of Australia approval of ...

July 10, 2013 | Wednesday | News
Austrianova's trial data proves efficacy

Singapore: Singapore-based Austrianova presented additional safety and efficacy data from a second phase II pancreatic c...

October 15, 2012 | Monday | News
Genentech skin hive drug shows +ve results

Singapore: Genentech's omalizumab has shown success in reducing disease severity in patients with moderate to severe chr...

February 25, 2013 | Monday | News
EU patent for Phylomer ischemia peptides

Singapore: Phylogica has been granted a new European patent (no. 1793841) entitled: 'Peptide inhibitors of c-Jun dimeriz...

April 25, 2013 | Thursday | News
Thermo Fisher Scientific to support research in NUS

Singapore: Thermo Fisher Scientific and National University of Singapore (NUS) have entered into a strategic alliance to...

April 14, 2014 | Monday | News
Daiichi Sankyo reports positive results for tivantinib

Singapore: Biotech company ArQule and Japan-based Daiichi Sankyo have achieved positive results from a randomized, place...

June 4, 2012 | Monday | News
Eisai expands its anti-obesity drug market

Singapore: Global pharmaceutical firm, Eisai has expanded the marketing and supply agreement between its U.S. subsidiary...

November 8, 2013 | Friday | News
Merck gets cancer drug license from Symphogen

Singapore: Symphogen signed an exclusive worldwide license agreement with Merck in Germany for Sym004, an investigationa...

September 6, 2012 | Thursday | News
Kinex receives funds from Hong Kong govt ITC

Singapore: US-based Kinex Pharmaceuticals's application for the Small Entrepreneur Research Assistance Programme has bee...

August 2, 2013 | Friday | News
Singapore's first flu vaccine clears phase I trial

Singapore: Influenza vaccine (gH1-Qbeta) developed by Singapore's Agency for Science, Technology and Research (A*STAR) a...

January 30, 2014 | Thursday | News
Exjade gets FDA nod for iron overload treatment

Singapore: The US FDA has approved Exjade (deferasirox) for the treatment of chronic iron overload in patients 10 years...

January 24, 2013 | Thursday | Regulatory
Customized treatments to dominate oncology therapy

Singapore: Cancer treatments are becoming increasingly personalized, as regulators are approving therapeutics offering s...

July 11, 2012 | Wednesday | Analysis